Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia

September 5, 2017 updated by: Dr Aida Mastura Mohd Shah, Kuala Lumpur General Hospital

Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia : Ultrasound-Guided Fascia Iliaca Compartment Block Versus Intravenous Fentanyl

This study is performed to determine the efficacy of ultrasound-guided fascia iliaca compartment block during positioning for spinal anaesthesia in patient undergoing repair of proximal femur fracture surgery comparing with intravenous fentanyl.

Study Overview

Status

Completed

Conditions

Detailed Description

This a prospective, single-blind, randomized control study that compare the efficacy of ultrasound-guided fascia iliaca compartment block with intravenous fentanyl in positioning patient with femur fracture for spinal anaesthesia.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wilayah Persekutuan
      • Kuala Lumpur, Wilayah Persekutuan, Malaysia, 50586
        • Kuala Lumpur General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • American Society of Anaesthesiologists (ASA) score I and II
  • Elective surgery of repair of unilateral, single femoral fracture under spinal anaesthesia performed in General Operation Theatre, Hospital Kuala Lumpur. The fracture may involve femoral neck or femoral shaft.

Exclusion Criteria:

  • Patient with contraindication for spinal anaesthesia
  • Known hypersensitivity or contraindication to medication used in this study
  • Morbid obesity (body mass index (BMI) > 35 kg/m2)
  • Infection at the intended site of administration of fascia iliaca compartment block
  • Patient with impaired cognitive function

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: fascia iliaca compartment block
Patient will receive 40ml of ropivacaine 0.375% at the fascia iliaca compartment under the guidance of ultrasound. It will be given 20 minutes before patient is positioned for spinal anaesthesia
Fascia iliaca compartment block using ropivacaine
Ultrasound-guided fascia iliaca compartment block
Active Comparator: intravenous fentanyl
Patient will receive 0.5 mcg/kg of intravenous fentanyl. It will be given 5 minutes before patient is positioned for spinal anaesthesia
Intravenous fentanyl

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain score during positioning
Time Frame: Group 1: 20 minutes after intervention (block), Group 2: 5 minutes after intervention (fentanyl)
Pain score is assessed using Visual Analogue Scale (VAS) score
Group 1: 20 minutes after intervention (block), Group 2: 5 minutes after intervention (fentanyl)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ease of positioning for spinal anaesthesia
Time Frame: Group 1: 20 minutes after intervention (block), Group 2: 5 minutes after intervention (fentanyl)
It will be characterized as 'very difficult', 'difficult', 'easy' and 'very easy'
Group 1: 20 minutes after intervention (block), Group 2: 5 minutes after intervention (fentanyl)
Patient satisfaction
Time Frame: 24 hours after intervention
Patient will be asked whether they will choose the same analgesic technique in the event of future operation : 'yes' or 'no'.
24 hours after intervention
Adverse effects
Time Frame: Up to 24 hours of intervention
Up to 24 hours of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Raha Abdul Rahman, MBBS, Universiti Kebangsaan Malaysia Medical Centre
  • Principal Investigator: Azrin Mohd Azidin, MBBS, Kuala Lumpur General Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

November 29, 2016

First Submitted That Met QC Criteria

December 2, 2016

First Posted (Estimate)

December 6, 2016

Study Record Updates

Last Update Posted (Actual)

September 6, 2017

Last Update Submitted That Met QC Criteria

September 5, 2017

Last Verified

September 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Femoral Fracture

Clinical Trials on Ropivacaine

3
Subscribe